Tandem Investment Advisors Inc. raised its position in Genpact Limited (NYSE:G – Free Report) by 390.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,129,915 shares of the business services provider’s stock after acquiring an additional 1,695,706 shares during the period. Genpact comprises approximately 3.5% of Tandem Investment Advisors Inc.’s holdings, making the stock its 11th largest holding. Tandem Investment Advisors Inc.’s holdings in Genpact were worth $91,480,000 at the end of the most recent reporting period.
A number of other hedge funds also recently modified their holdings of G. Creative Planning raised its stake in shares of Genpact by 19.4% in the 3rd quarter. Creative Planning now owns 30,590 shares of the business services provider’s stock valued at $1,199,000 after buying an additional 4,976 shares in the last quarter. Sequoia Financial Advisors LLC raised its position in Genpact by 5.8% in the third quarter. Sequoia Financial Advisors LLC now owns 23,315 shares of the business services provider’s stock worth $914,000 after purchasing an additional 1,281 shares in the last quarter. Signaturefd LLC lifted its stake in Genpact by 10.4% during the third quarter. Signaturefd LLC now owns 17,069 shares of the business services provider’s stock worth $669,000 after purchasing an additional 1,611 shares during the period. Lecap Asset Management Ltd. boosted its holdings in Genpact by 2.1% during the third quarter. Lecap Asset Management Ltd. now owns 18,059 shares of the business services provider’s stock valued at $708,000 after purchasing an additional 364 shares in the last quarter. Finally, Greenleaf Trust acquired a new stake in Genpact during the third quarter valued at approximately $210,000. Institutional investors own 96.03% of the company’s stock.
Genpact Stock Down 1.0 %
Shares of NYSE G opened at $54.44 on Friday. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $56.76. The firm’s 50-day simple moving average is $46.83 and its 200 day simple moving average is $42.59. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. The company has a market cap of $9.60 billion, a price-to-earnings ratio of 19.17, a price-to-earnings-growth ratio of 1.85 and a beta of 1.20.
Genpact Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be paid a $0.17 dividend. This is a boost from Genpact’s previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a dividend yield of 1.25%. The ex-dividend date is Tuesday, March 11th. Genpact’s dividend payout ratio (DPR) is 21.48%.
Insider Transactions at Genpact
In other Genpact news, SVP Piyush Mehta sold 12,000 shares of the firm’s stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. This trade represents a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the company’s stock in a transaction on Friday, December 13th. The shares were sold at an average price of $44.60, for a total transaction of $606,560.00. Following the sale, the chief executive officer now owns 267,404 shares of the company’s stock, valued at $11,926,218.40. The trade was a 4.84 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 34,600 shares of company stock worth $1,538,120 over the last 90 days. 2.80% of the stock is owned by insiders.
Wall Street Analyst Weigh In
A number of equities analysts have recently issued reports on G shares. Needham & Company LLC raised their target price on Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Robert W. Baird lifted their price objective on Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a report on Friday, November 8th. Jefferies Financial Group upgraded shares of Genpact from a “hold” rating to a “buy” rating and boosted their target price for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Mizuho increased their target price on shares of Genpact from $45.00 to $55.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Finally, TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and boosted their price target for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Six analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, Genpact has a consensus rating of “Hold” and an average target price of $48.44.
Get Our Latest Report on Genpact
Genpact Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles
- Five stocks we like better than Genpact
- Roth IRA Calculator: Calculate Your Potential Returns
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- How to Start Investing in Real Estate
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- How to buy stock: A step-by-step guide for beginners
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.